This inventor holds 18 USPTO granted patents and 2 published patent applications and 7 EPO patents, primarily in Chemical Compounds. Top assignees: Glaxosmithkline LLC, Smithkline Beecham Corporation, Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2001-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Phoenixville, PA (US) (2001 - 2002)
- Trappe, PA (US) (2006)
- King of Prussia, PA (US) (2009)
- Collegevile, PA (US) (2017)
- Collegeville, PA (US) (2002 - 2019)
Company Filing History:
8 out of 358 
6 out of 2,198 
3 out of 95 
Years Active: 2001-2019
Areas of Expertise:
Title: The Innovative Journey of Joelle Lorraine Burgess: A Pioneer in Cancer Therapy
Introduction: Joelle Lorraine Burgess, based in Collegeville, PA, is a remarkable inventor known for her significant contributions to the field of cancer therapeutics. With a total of 18 patents to her name, Joelle has made substantial strides in developing innovative solutions for the treatment of various cancers.
Latest Patents: Among her latest inventions are the "Enhancer of Zeste Homolog 2 inhibitors." This groundbreaking patent details novel substituted benzamides, which function as inhibitors of the Enhancer of Zeste Homolog 2 (EZH2). These compounds are pivotal in pharmaceutical compositions, offering new therapeutic options for cancer treatment. The detailed processes for their preparation further underscore the potential impact of her inventions on modern medicine.
Career Highlights: Throughout her career, Joelle has excelled in advancing research and development initiatives in the pharmaceutical industry. Notable companies she has been associated with include GlaxoSmithKline LLC and SmithKline Beecham Corporation. Her work has consistently aimed at harnessing the power of innovative chemistry to address critical healthcare challenges.
Collaborations: Joelle has worked alongside esteemed colleagues such as Steven David Knight and James Francis Callahan. These collaborations not only reflect her ability to foster synergistic relationships but also emphasize her commitment to advancing science through teamwork and shared expertise.
Conclusion: Joelle Lorraine Burgess stands as a testament to the power of innovation in the fight against cancer. Her extensive patent portfolio and collaborative efforts highlight her influential role as an inventor and researcher. As therapies continue to evolve, her contributions will undoubtedly pave the way for improved treatment options and advancements in cancer research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile